Evaluation of quality of life in patients with previously untreated advanced prostate cancer receiving maximum androgen blockade therapy or LHRHa monotherapy: a multicenter, randomized, double-blind, comparative study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples